Management of Acute Changes in Meningioma

Immediate Assessment and Stabilization

Clinical Evaluation Priority

• Document Glasgow Coma Scale score immediately to establish baseline neurological status and monitor for deterioration 1
• Assess for focal neurological deficits including subtle weakness, sensory changes, cranial nerve palsies, or visual field defects based on tumor location 1
• Evaluate for signs of increased intracranial pressure: headache, vomiting, papilloedema, altered consciousness 1
• In posterior fossa lesions, specifically assess for brainstem compression symptoms (cranial nerve dysfunction, ataxia, respiratory changes) 1

Diagnostic Imaging Algorithm

First-Line Imaging

• MRI with contrast is the gold standard for characterizing acute changes in known or suspected meningioma 1, 2
• Look for: homogeneous dural-based enhancement, dural tail sign, peritumoral edema, mass effect, and hemorrhage 1, 2
• CT scan should be used if MRI is contraindicated or unavailable, particularly useful for detecting acute hemorrhage and calcifications 1, 3

Advanced Imaging Considerations

• Somatostatin receptor (SSTR) PET imaging should be considered when diagnosis is uncertain or to differentiate tumor progression from treatment-related changes 1, 2
• Elevated SSTR uptake has high positive predictive value for meningioma and helps distinguish from mimics such as metastases, gliomas, or lymphoma 1

Acute Medical Management

Seizure Management

• Administer appropriate antiepileptic medication immediately for any seizure activity 1
• Consider continuous monitoring during imaging studies in patients with seizures 1
• Seizures are a recognized acute complication, particularly in patients undergoing peptide receptor radionuclide therapy (PRRT) 4, 5, 6

Management of Increased Intracranial Pressure

• Initiate dexamethasone to reduce peritumoral edema in patients with significant mass effect or neurological symptoms 1, 3
• High-dose steroids combined with head elevation and close neurological monitoring for post-operative or acute symptomatic swelling 3
• Maintain vigilance for rapid deterioration, as intracranial lesions can progress quickly 1

Acute Post-Treatment Complications (PRRT-Related)

• Prescribe antiepileptic drugs for acute post-treatment seizures in patients undergoing radionuclide therapy 4, 5, 6
• Prescribe corticosteroids for signs of intracranial hypertension in patients undergoing radionuclide therapy 4, 5, 6
• Hydrate with normal saline and repeat antiemetic administration for metabolic acidosis-related symptoms in patients undergoing radionuclide therapy 4, 5, 6

Neurosurgical Consultation Criteria

Immediate Consultation Required

• Any patient with significant neurological symptoms or evidence of brainstem compression requires immediate neurosurgical consultation 1
• Rapid neurological deterioration or declining Glasgow Coma Scale requires immediate neurosurgical consultation 1
• Signs of herniation or severe mass effect require immediate neurosurgical consultation 1

Specialized Surgical Expertise

• Skull base meningiomas require specialized neurosurgical expertise and multidisciplinary approach 1, 3
• Intraventricular meningiomas need careful surgical planning with higher risk of significant blood loss 1, 3
• Pediatric cases should involve specialized pediatric neurosurgical expertise 7, 1

Treatment Decision Algorithm Based on Acuity

Emergency Surgical Intervention

• Progressive neurological deterioration despite medical management requires emergency surgical intervention 1
• Brainstem compression in posterior fossa lesions requires emergency surgical intervention 1

Urgent Surgical Planning (24-72 hours)

• Symptomatic meningiomas with significant but stable mass effect require urgent surgical planning 3, 2
• New-onset seizures with accessible lesion require urgent surgical planning 1, 2
• Progressive symptoms over days to weeks require urgent surgical planning 2

Medical Management with Close Monitoring

• Mild symptoms responsive to corticosteroids can be managed medically with close monitoring 1, 3
• Small asymptomatic lesions discovered incidentally during acute workup can be managed medically with close monitoring 2
• Patients with significant comorbidities requiring optimization before surgery can be managed medically with close monitoring 2

Critical Pitfalls to Avoid

• Do not assume all enhancing dural-based lesions are meningiomas—metastases, gliomas, and primary CNS lymphoma can mimic meningiomas 1
• Do not underestimate potential for significant blood loss, particularly with large hemispheric or intraventricular tumors 1, 3
• Do not overlook the need for specialized surgical expertise for complex locations such as skull base, cavernous sinus, or intraventricular locations 1, 3
• Do not delay hospital admission or imaging when acute neurological changes occur, even if symptoms seem mild initially 1

Special Population Considerations

Pediatric Patients

• Pediatric meningiomas are more likely to present with calcifications and cystic transformation 1
• Pediatric meningiomas require specialized pediatric neurosurgical expertise 7, 1
• Blood loss during surgery has relatively greater impact in pediatric patients due to smaller blood volume 7, 3

Post-PRRT Patients

• Monitor for acute seizures and intracranial hypertension as specific complications in post-PRRT patients 4, 5, 6
• Maintain awareness of potential symptomatic edema or radionecrosis as delayed acute presentations in post-PRRT patients 4, 5, 8